Colgate-Palmolive SEC filings, summarized
We read every Colgate-Palmolive 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track CL in your inbox
Add Colgate-Palmolive to your watchlist — free, every morning.
Recent filings
Colgate-Palmolive reports higher sales and raises adjusted 2026 EPS outlook
Colgate-Palmolive reported second-quarter 2026 net sales of $5.361 billion, up 4.9% from a year earlier, while organic sales rose 2.4%; GAAP diluted EPS…
COLGATE-PALMOLIVE ($CL) filed Item 9.01 on Mar 17, 2026 — Exhibit 99: recast segment information; Exhibit…
COLGATE-PALMOLIVE ($CL) filed Item 9.01 on Mar 17, 2026 — Exhibit 99: recast segment information; Exhibit 104: Inline XBRL cover page. 📊📄 #SECfiling…
Colgate-Palmolive realigns reporting effective Q1’26 (quarter ending Mar 31, 2026): Europe +…
Colgate-Palmolive realigns reporting effective Q1’26 (quarter ending Mar 31, 2026): Europe + Africa/Eurasia (ex-Russia/Belarus) and Skin Health (from North…
Colgate-Palmolive ($CL) elected Christopher S.
Colgate-Palmolive ($CL) elected Christopher S. Boerner (55) to its Board, effective Mar 15, 2026. Boerner is CEO (since Nov 2023) and Board Chair (since Apr…
Colgate-Palmolive filed an 8-K (Item 9.01) on Jan 30, 2026 — Exhibits: 99 (press release dated Jan 30,…
Colgate-Palmolive filed an 8-K (Item 9.01) on Jan 30, 2026 — Exhibits: 99 (press release dated Jan 30, 2026) and 104 (Inline XBRL cover page). Filing signed…
Colgate-Palmolive issued a press release on Jan 30, 2026 announcing earnings for the quarter and year…
Colgate-Palmolive issued a press release on Jan 30, 2026 announcing earnings for the quarter and year ended Dec 31, 2025. See Exhibit 99 for full results.…